Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis.

Codullo V, Cova E, Pandolfi L, Breda S, Morosini M, Frangipane V, Malatesta M, Calderan L, Cagnone M, Pacini C, Cavagna L, Recalde H, Distler JHW, Giustra M, Prosperi D, Colombo M, Meloni F, Montecucco C.

J Control Release. 2019 Aug 17;310:198-208. doi: 10.1016/j.jconrel.2019.08.015. [Epub ahead of print]

PMID:
31430501
2.

Are nanotechnological approaches the future of treating inflammatory diseases?

Rizzuto MA, Salvioni L, Rotem R, Colombo M, Zanoni I, Granucci F, Prosperi D.

Nanomedicine (Lond). 2019 Sep;14(17):2379-2390. doi: 10.2217/nnm-2019-0159. Epub 2019 Aug 15.

PMID:
31414616
3.

Role of Combined [68Ga]Ga-DOTA-SST Analogues and [18F]FDG PET/CT in the Management of GEP-NENs: A Systematic Review.

Carideo L, Prosperi D, Panzuto F, Magi L, Pratesi MS, Rinzivillo M, Annibale B, Signore A.

J Clin Med. 2019 Jul 13;8(7). pii: E1032. doi: 10.3390/jcm8071032. Review.

4.

Multidisciplinary Management of Neuroendocrine Neoplasia: A Real-World Experience from a Referral Center.

Magi L, Mazzuca F, Rinzivillo M, Arrivi G, Pilozzi E, Prosperi D, Iannicelli E, Mercantini P, Rossi M, Pizzichini P, Laghi A, Signore A, Marchetti P, Annibale B, Panzuto F.

J Clin Med. 2019 Jun 25;8(6). pii: E910. doi: 10.3390/jcm8060910.

5.

Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial.

Cox MC, Castiello L, Mattei M, Santodonato L, D'Agostino G, Muraro E, Martorelli D, Lapenta C, Di Napoli A, Di Landro F, Cangemi M, Pavan A, Castaldo P, Hohaus S, Donati S, Montefiore E, Berdini C, Carlei D, Monque DM, Ruco L, Prosperi D, Tafuri A, Spadaro F, Sestili P, Spada M, Dolcetti R, Santini SM, Rozera C, Aricò E, Capone I, Belardelli F.

Clin Cancer Res. 2019 Sep 1;25(17):5231-5241. doi: 10.1158/1078-0432.CCR-19-0709. Epub 2019 Jun 6.

PMID:
31171545
6.

Suicide Gene Therapy: A New Frontier for Cancer Fighting.

Prosperi D, Colombo M.

Curr Pharm Biotechnol. 2019;20(1):2-4. doi: 10.2174/138920102001190306102136. No abstract available.

PMID:
31002032
7.

Multifunctional Magnetic Gold Nanomaterials for Cancer.

Das P, Fatehbasharzad P, Colombo M, Fiandra L, Prosperi D.

Trends Biotechnol. 2019 Sep;37(9):995-1010. doi: 10.1016/j.tibtech.2019.02.005. Epub 2019 Mar 9. Review.

PMID:
30862388
8.

Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study.

Cova E, Pandolfi L, Colombo M, Frangipane V, Inghilleri S, Morosini M, Mrakic-Sposta S, Moretti S, Monti M, Pignochino Y, Benvenuti S, Prosperi D, Stella G, Morbini P, Meloni F.

Int J Nanomedicine. 2019 Jan 23;14:773-785. doi: 10.2147/IJN.S186344. eCollection 2019.

9.

The prognostic role of end of treatment FDG-PET-CT in patients with diffuse large B cell lymphoma can be improved by considering it with absolute monocyte count at diagnosis.

Marcheselli R, Franceschetto A, Sacchi S, Bari A, Levy I, Pizzichini P, Prosperi D, D'Apollo R, Massi L, Casolo A, Pozzi S, Marcheselli L, Tadmor T, Prandini N, Cox MC.

Leuk Lymphoma. 2019 Aug;60(8):1958-1964. doi: 10.1080/10428194.2018.1564049. Epub 2019 Jan 28.

PMID:
30689474
10.

Recent advances in magnetic fluid hyperthermia for cancer therapy.

Das P, Colombo M, Prosperi D.

Colloids Surf B Biointerfaces. 2019 Feb 1;174:42-55. doi: 10.1016/j.colsurfb.2018.10.051. Epub 2018 Oct 24. Review.

PMID:
30428431
11.

Half-Chain Cetuximab Nanoconjugates Allow Multitarget Therapy of Triple Negative Breast Cancer.

Colombo M, Rizzuto MA, Pacini C, Pandolfi L, Bonizzi A, Truffi M, Monieri M, Catrambone F, Giustra M, Garbujo S, Fiandra L, Corsi F, Prosperi D, Mazzucchelli S.

Bioconjug Chem. 2018 Nov 21;29(11):3817-3832. doi: 10.1021/acs.bioconjchem.8b00667. Epub 2018 Oct 25.

PMID:
30350574
12.

A fast and straightforward procedure for vault nanoparticle purification and the characterization of its endocytic uptake.

Galbiati E, Avvakumova S, La Rocca A, Pozzi M, Messali S, Magnaghi P, Colombo M, Prosperi D, Tortora P.

Biochim Biophys Acta Gen Subj. 2018 Oct;1862(10):2254-2260. doi: 10.1016/j.bbagen.2018.07.018. Epub 2018 Jul 20.

PMID:
30036602
13.

Preface: A New Era of Nanoimmunology.

Prosperi D.

Curr Pharm Biotechnol. 2018;19(1):2-4. doi: 10.2174/138920101901180531113953. No abstract available.

PMID:
29962331
14.

Heteronanoparticles by Self-Assembly of Ecdysteroid and Doxorubicin Conjugates To Overcome Cancer Resistance.

Fumagalli G, Giorgi G, Vágvölgyi M, Colombo E, Christodoulou MS, Collico V, Prosperi D, Dosio F, Hunyadi A, Montopoli M, Hyeraci M, Silvani A, Lesma G, Via LD, Passarella D.

ACS Med Chem Lett. 2018 Apr 17;9(5):468-471. doi: 10.1021/acsmedchemlett.8b00078. eCollection 2018 May 10.

15.

Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells.

Truffi M, Colombo M, Sorrentino L, Pandolfi L, Mazzucchelli S, Pappalardo F, Pacini C, Allevi R, Bonizzi A, Corsi F, Prosperi D.

Sci Rep. 2018 Apr 26;8(1):6563. doi: 10.1038/s41598-018-24968-x.

16.

New SPECT and PET Radiopharmaceuticals for Imaging Inflammatory Diseases: A Meta-analysis of the Last 10 Years.

Pacilio M, Lauri C, Prosperi D, Petitti A, Signore A.

Semin Nucl Med. 2018 May;48(3):261-276. doi: 10.1053/j.semnuclmed.2017.12.004. Epub 2018 Feb 1. Review. Erratum in: Semin Nucl Med. 2018 Nov;48(6):484.

PMID:
29626943
17.

Conformational properties of intrinsically disordered proteins bound to the surface of silica nanoparticles.

Vitali M, Rigamonti V, Natalello A, Colzani B, Avvakumova S, Brocca S, Santambrogio C, Narkiewicz J, Legname G, Colombo M, Prosperi D, Grandori R.

Biochim Biophys Acta Gen Subj. 2018 Jul;1862(7):1556-1564. doi: 10.1016/j.bbagen.2018.03.026. Epub 2018 Apr 2.

PMID:
29621630
18.

Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles.

Colzani B, Pandolfi L, Hoti A, Iovene PA, Natalello A, Avvakumova S, Colombo M, Prosperi D.

Int J Nanomedicine. 2018 Feb 14;13:957-973. doi: 10.2147/IJN.S152742. eCollection 2018.

19.

Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity.

Riva B, Bellini M, Corvi E, Verderio P, Rozek E, Colzani B, Avvakumova S, Radeghieri A, Rizzuto MA, Morasso C, Colombo M, Prosperi D.

J Colloid Interface Sci. 2018 Jun 1;519:18-26. doi: 10.1016/j.jcis.2018.02.040. Epub 2018 Feb 14.

PMID:
29477896
20.

Nanoparticles: "magic bullets" for targeting the immune system.

Granucci F, Prosperi D.

Semin Immunol. 2017 Dec;34:1-2. doi: 10.1016/j.smim.2017.10.002. No abstract available.

PMID:
29173493
21.

Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms.

Rinzivillo M, Partelli S, Prosperi D, Capurso G, Pizzichini P, Iannicelli E, Merola E, Muffatti F, Scopinaro F, Schillaci O, Salgarello M, Falconi M, Delle Fave G, Panzuto F.

Oncologist. 2018 Feb;23(2):186-192. doi: 10.1634/theoncologist.2017-0278. Epub 2017 Nov 8.

22.

Innovative approach to safely induce controlled lipolysis by superparamagnetic iron oxide nanoparticles-mediated hyperthermic treatment.

Marinozzi MR, Pandolfi L, Malatesta M, Colombo M, Collico V, Lievens PM, Tambalo S, Lasconi C, Vurro F, Boschi F, Mannucci S, Sbarbati A, Prosperi D, Calderan L.

Int J Biochem Cell Biol. 2017 Dec;93:62-73. doi: 10.1016/j.biocel.2017.10.013. Epub 2017 Oct 27.

PMID:
29111382
23.

H-Ferritin Enriches the Curcumin Uptake and Improves the Therapeutic Efficacy in Triple Negative Breast Cancer Cells.

Pandolfi L, Bellini M, Vanna R, Morasso C, Zago A, Carcano S, Avvakumova S, Bertolini JA, Rizzuto MA, Colombo M, Prosperi D.

Biomacromolecules. 2017 Oct 9;18(10):3318-3330. doi: 10.1021/acs.biomac.7b00974. Epub 2017 Sep 19.

PMID:
28886247
24.

Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases.

Prosperi D, Colombo M, Zanoni I, Granucci F.

Semin Immunol. 2017 Dec;34:61-67. doi: 10.1016/j.smim.2017.08.010. Epub 2017 Aug 30. Review.

25.

H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer.

Mazzucchelli S, Truffi M, Baccarini F, Beretta M, Sorrentino L, Bellini M, Rizzuto MA, Ottria R, Ravelli A, Ciuffreda P, Prosperi D, Corsi F.

Sci Rep. 2017 Aug 8;7(1):7505. doi: 10.1038/s41598-017-07617-7.

26.

Nano-targeting of mucosal addressin cell adhesion molecule-1 identifies bowel inflammation foci in murine model.

Truffi M, Colombo M, Peñaranda-Avila J, Sorrentino L, Colombo F, Monieri M, Collico V, Zerbi P, Longhi E, Allevi R, Prosperi D, Corsi F.

Nanomedicine (Lond). 2017 Jul;12(13):1547-1560. doi: 10.2217/nnm-2017-0004. Epub 2017 Jun 16.

27.

Development of 99mTc-radiolabeled nanosilica for targeted detection of HER2-positive breast cancer.

Rainone P, Riva B, Belloli S, Sudati F, Ripamonti M, Verderio P, Colombo M, Colzani B, Gilardi MC, Moresco RM, Prosperi D.

Int J Nanomedicine. 2017 May 2;12:3447-3461. doi: 10.2147/IJN.S129720. eCollection 2017.

28.

Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents.

Cova E, Inghilleri S, Pandolfi L, Morosini M, Magni S, Colombo M, Piloni D, Finetti C, Ceccarelli G, Benedetti L, Cusella MG, Agozzino M, Corsi F, Allevi R, Mrakic-Sposta S, Moretti S, De Gregori S, Prosperi D, Meloni F.

Nanotoxicology. 2017 May;11(4):534-545. doi: 10.1080/17435390.2017.1317862. Epub 2017 Apr 27.

PMID:
28415888
29.

Negatively charged silver nanoparticles with potent antibacterial activity and reduced toxicity for pharmaceutical preparations.

Salvioni L, Galbiati E, Collico V, Alessio G, Avvakumova S, Corsi F, Tortora P, Prosperi D, Colombo M.

Int J Nanomedicine. 2017 Mar 31;12:2517-2530. doi: 10.2147/IJN.S127799. eCollection 2017.

30.

Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications.

Merola E, Pavel ME, Panzuto F, Capurso G, Cicchese N, Rinke A, Gress TM, Iannicelli E, Prosperi D, Pizzichini P, Prasad V, Kump P, Lipp R, Partelli S, Falconi M, Wiedenmann B, Delle Fave G.

J Clin Endocrinol Metab. 2017 May 1;102(5):1486-1494. doi: 10.1210/jc.2016-3732.

PMID:
28324047
31.

Impact of semi-solid formulations on skin penetration of iron oxide nanoparticles.

Musazzi UM, Santini B, Selmin F, Marini V, Corsi F, Allevi R, Ferretti AM, Prosperi D, Cilurzo F, Colombo M, Minghetti P.

J Nanobiotechnology. 2017 Feb 17;15(1):14. doi: 10.1186/s12951-017-0249-6.

32.

Is bigger still better? Walking on the trail of cancer nanomedicine.

Prosperi D, Corsi F.

Pharmacol Res. 2017 May;119:149-152. doi: 10.1016/j.phrs.2017.01.030. Epub 2017 Jan 30. No abstract available.

33.

Correction: Self-assembled 4-(1,2-diphenylbut-1-en-1-yl)aniline based nanoparticles: podophyllotoxin and aloin as building blocks.

Fumagalli G, Christodoulou MS, Riva B, Revuelta I, Marucci C, Collico V, Prosperi D, Riva S, Perdicchia D, Bassanini I, García-Argáez A, Via LD, Passarella D.

Org Biomol Chem. 2017 Feb 21;15(7):1725. doi: 10.1039/c7ob90018j. Epub 2017 Feb 2.

PMID:
28150007
34.

Self-assembled 4-(1,2-diphenylbut-1-en-1-yl)aniline based nanoparticles: podophyllotoxin and aloin as building blocks.

Fumagalli G, Christodoulou MS, Riva B, Revuelta I, Marucci C, Collico V, Prosperi D, Riva S, Perdicchia D, Bassanini I, García-Argáez A, Via LD, Passarella D.

Org Biomol Chem. 2017 Feb 1;15(5):1106-1109. doi: 10.1039/c6ob02591a.

PMID:
28093593
35.

Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity.

Mazzucchelli S, Bellini M, Fiandra L, Truffi M, Rizzuto MA, Sorrentino L, Longhi E, Nebuloni M, Prosperi D, Corsi F.

Oncotarget. 2017 Jan 31;8(5):8383-8396. doi: 10.18632/oncotarget.14204.

36.

Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies.

Colombo M, Fiandra L, Alessio G, Mazzucchelli S, Nebuloni M, De Palma C, Kantner K, Pelaz B, Rotem R, Corsi F, Parak WJ, Prosperi D.

Nat Commun. 2016 Dec 19;7:13818. doi: 10.1038/ncomms13818.

37.

Digital Detection of Exosomes by Interferometric Imaging.

Daaboul GG, Gagni P, Benussi L, Bettotti P, Ciani M, Cretich M, Freedman DS, Ghidoni R, Ozkumur AY, Piotto C, Prosperi D, Santini B, Ünlü MS, Chiari M.

Sci Rep. 2016 Nov 17;6:37246. doi: 10.1038/srep37246.

38.

Theranostic Nanocages for Imaging and Photothermal Therapy of Prostate Cancer Cells by Active Targeting of Neuropeptide-Y Receptor.

Avvakumova S, Galbiati E, Sironi L, Locarno SA, Gambini L, Macchi C, Pandolfi L, Ruscica M, Magni P, Collini M, Colombo M, Corsi F, Chirico G, Romeo S, Prosperi D.

Bioconjug Chem. 2016 Dec 21;27(12):2911-2922. doi: 10.1021/acs.bioconjchem.6b00568. Epub 2016 Nov 18.

39.

Nanoparticle-mediated delivery of suicide genes in cancer therapy.

Vago R, Collico V, Zuppone S, Prosperi D, Colombo M.

Pharmacol Res. 2016 Sep;111:619-641. doi: 10.1016/j.phrs.2016.07.007. Epub 2016 Jul 18. Review.

PMID:
27436147
40.

Click Chemistry Immobilization of Antibodies on Polymer Coated Gold Nanoparticles.

Finetti C, Sola L, Pezzullo M, Prosperi D, Colombo M, Riva B, Avvakumova S, Morasso C, Picciolini S, Chiari M.

Langmuir. 2016 Jul 26;32(29):7435-41. doi: 10.1021/acs.langmuir.6b01142. Epub 2016 Jul 11.

PMID:
27367748
41.

"Blind" targeting in action: From phage display to breast cancer cell targeting with peptide-gold nanoconjugates.

Galbiati E, Gambini L, Civitarese V, Bellini M, Ambrosini D, Allevi R, Avvakumova S, Romeo S, Prosperi D.

Pharmacol Res. 2016 Sep;111:155-162. doi: 10.1016/j.phrs.2016.06.007. Epub 2016 Jun 9.

PMID:
27293049
42.

A Case of Pancreatic Small Cell Neuroendocrine Carcinoma Associated With SIADH.

Pescatori LC, Festa S, Panzuto F, Pilozzi E, Prosperi D, Rinzivillo M, Pizzichini P, Iaquinto G, Iannicelli E, Mené P, Delle Fave G, Capurso G.

Pancreas. 2016 May-Jun;45(5):e20-2. doi: 10.1097/MPA.0000000000000558. No abstract available.

PMID:
27077720
43.

Loss of exosomes in progranulin-associated frontotemporal dementia.

Benussi L, Ciani M, Tonoli E, Morbin M, Palamara L, Albani D, Fusco F, Forloni G, Glionna M, Baco M, Paterlini A, Fostinelli S, Santini B, Galbiati E, Gagni P, Cretich M, Binetti G, Tagliavini F, Prosperi D, Chiari M, Ghidoni R.

Neurobiol Aging. 2016 Apr;40:41-49. doi: 10.1016/j.neurobiolaging.2016.01.001. Epub 2016 Jan 7.

PMID:
26973102
44.

Diagnosis and follow-up of idiopathic retroperitoneal fibrosis: role of (18)F-FDG-PET/CT and biochemical parameters in patients with renal involvement.

Fofi C, Prosperi D, Pettorini L, Festuccia F, Pirisino R, Lanni V, Scopinaro F, Punzo G, Menè P.

Intern Emerg Med. 2016 Sep;11(6):809-16. doi: 10.1007/s11739-016-1426-6. Epub 2016 Mar 12.

PMID:
26970988
45.

Combined mass quantitation and phenotyping of intact extracellular vesicles by a microarray platform.

Gagni P, Cretich M, Benussi L, Tonoli E, Ciani M, Ghidoni R, Santini B, Galbiati E, Prosperi D, Chiari M.

Anal Chim Acta. 2016 Jan 1;902:160-167. doi: 10.1016/j.aca.2015.10.017. Epub 2015 Oct 26.

PMID:
26703266
46.

Stem Cell-Mediated Exon Skipping of the Dystrophin Gene by the Bystander Effect.

Meregalli M, Farini A, Sitzia C, Beley C, Razini P, Cassinelli L, Colleoni F, Frattini P, Santo N, Galbiati E, Prosperi D, Tavelli A, Belicchi M, Garcia L, Torrente Y.

Curr Gene Ther. 2015;15(6):563-71.

PMID:
26415573
47.

Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice.

Fiandra L, Colombo M, Mazzucchelli S, Truffi M, Santini B, Allevi R, Nebuloni M, Capetti A, Rizzardini G, Prosperi D, Corsi F.

Nanomedicine. 2015 Aug;11(6):1387-97. doi: 10.1016/j.nano.2015.03.009. Epub 2015 Apr 1.

48.

Peptide-nanoparticle ligation mediated by cutinase fusion for the development of cancer cell-targeted nanoconjugates.

Galbiati E, Cassani M, Verderio P, Martegani E, Colombo M, Tortora P, Mazzucchelli S, Prosperi D.

Bioconjug Chem. 2015 Apr 15;26(4):680-9. doi: 10.1021/acs.bioconjchem.5b00005. Epub 2015 Mar 13.

PMID:
25741889
49.

Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells.

Bellini M, Mazzucchelli S, Galbiati E, Sommaruga S, Fiandra L, Truffi M, Rizzuto MA, Colombo M, Tortora P, Corsi F, Prosperi D.

J Control Release. 2014 Dec 28;196:184-96. doi: 10.1016/j.jconrel.2014.10.002. Epub 2014 Oct 13.

PMID:
25312541
50.

Polymer nanopillar-gold arrays as surface-enhanced Raman spectroscopy substrate for the simultaneous detection of multiple genes.

Picciolini S, Mehn D, Morasso C, Vanna R, Bedoni M, Pellacani P, Marchesini G, Valsesia A, Prosperi D, Tresoldi C, Ciceri F, Gramatica F.

ACS Nano. 2014 Oct 28;8(10):10496-506. doi: 10.1021/nn503873d. Epub 2014 Oct 13.

PMID:
25280123

Supplemental Content

Loading ...
Support Center